HGH and Naltrexone Interaction: Synergistic | Peptide Database

The 2019 Isenmann et al. study at Freie Universitat Berlin demonstrated that ecdysterone supplementation (administered as spinach extract standardized to ecdysterone content) produced significantly greater increases in lean muscle mass compared to placebo over 10 weeks of resistance training in young, trained men. The highest-dose group gained approximately 2 kg more lean mass than placebo. These results, combined with earlier Soviet-era research and multiple animal studies, support ecdysterone as a meaningful natural anabolic agent. Participants in the Berlin study also showed greater improvements in one-repetition maximum bench press compared to placebo. Animal studies have demonstrated improved grip strength, endurance capacity, and force production with ecdysterone administration. The mechanism likely involves both increased muscle protein synthesis and improved calcium handling within muscle fibers, enhancing contractile efficiency. Preclinical evidence suggests ecdysterone accelerates recovery from exercise-induced muscle damage through anti-inflammatory effects and enhanced protein synthesis rates. Users frequently report reduced delayed-onset muscle soreness (DOMS) and improved training frequency tolerance. However, dedicated human recovery studies are limited. By promoting lean mass accretion without androgenic hormonal disruption, ecdysterone may support body recomposition (simultaneous fat loss and muscle gain) particularly in trained individuals on a structured nutrition plan. Some animal data suggest mild lipolytic effects, though this has not been convincingly demonstrated in human trials.

Reduces estradiol levels during testosterone or aromatizable anabolic steroid cycles to prevent the development of estrogen-driven breast tissue growth. Most effective when started proactively rather than reactively. Manages estrogen-mediated fluid retention and subcutaneous bloating that commonly accompanies testosterone or other aromatizable compounds, contributing to a leaner appearance and reduced blood pressure. Titrated at low doses to keep estradiol within a target range (typically 20-40 pg/mL in men) during hormone replacement or enhancement protocols. Requires bloodwork for proper calibration. FDA-approved as adjuvant and first-line treatment for hormone receptor-positive breast cancer in postmenopausal women. Demonstrated superior disease-free survival compared to tamoxifen in the landmark ATAC trial. Used off-label alongside TRT to manage estradiol elevations, particularly in men with high body fat who aromatize testosterone more readily. Some clinicians prescribe low-dose anastrozole as part of comprehensive TRT protocols. Helps maintain a favorable testosterone-to-estradiol ratio in men on supraphysiological testosterone doses. An excessively high ratio (crashed estrogen) is as problematic as a low ratio, so careful dosing is essential. Some men aromatize testosterone at higher rates due to genetics or elevated body fat. Low-dose anastrozole can help these individuals manage estrogen even on standard TRT doses.